2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Novel RP-HPLC–PDA method for comprehensive stability indicating and impurity profiling for concurrent estimation of abiraterone and Niraparib in bulk and tablet formulation
Abiraterone and Niraparib are widely used in cancer treatment particularly for managing prostate and ovarian cancers marketed with brand name Akeega. This study focuses on developing and validating an innovative, precise and stability-indicating RP-HPLC method designed to simultaneously quantify Abiraterone, Niraparib...